Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-25-316601
Filing Date
2025-12-12
Accepted
2025-12-11 21:31:32
Documents
6

Document Format Files

Seq Description Document Type Size
1 SC14D9C d593019dsc14d9c.htm SC14D9C 21975
2 EX-99.1 d593019dex991.htm EX-99.1 21087
3 EX-99.2 d593019dex992.htm EX-99.2 14049
4 EX-99.3 d593019dex993.htm EX-99.3 12472
5 EX-99.4 d593019dex994.htm EX-99.4 13107
6 EX-99.5 d593019dex995.htm EX-99.5 53129
  Complete submission text file 0001193125-25-316601.txt   137646
Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Filed by) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9226
Applied Therapeutics, Inc. (Subject) CIK: 0001697532 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-91017 | Film No.: 251566409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)